Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H38O2 |
Molecular Weight | 298.5038 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OC(C)C
InChI
InChIKey=XUGNVMKQXJXZCD-UHFFFAOYSA-N
InChI=1S/C19H38O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(20)21-18(2)3/h18H,4-17H2,1-3H3
Molecular Formula | C19H38O2 |
Molecular Weight | 298.5038 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.carecreations.basf.com/product-formulations/products/products-detail/ISOPROPYL%20PALMITATE/30528720 and http://www.ncbi.nlm.nih.gov/pubmed/17077540
Curator's Comment: Description was created based on several sources, including
https://www.carecreations.basf.com/product-formulations/products/products-detail/ISOPROPYL%20PALMITATE/30528720 and http://www.ncbi.nlm.nih.gov/pubmed/17077540
Isopropyl palmitate is the ester of isopropyl alcohol and palmitic acid. It is an emollient, moisturizer, thickening agent, and anti-static agent. Isopropyl Palmitate is a traditional, fast spreading emollient for modern cosmetic applications. Isopropyl palmitate is approved by ECOCERT for Natural and Organic Cosmetics. It is on FDA CFR - Code of Federal Regulations Title 21 list.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4349 Sources: http://www.ncbi.nlm.nih.gov/pubmed/7284784 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Effect of hydrophobic permeation enhancers on the release and skin permeation kinetics from matrix type transdermal drug delivery system of ketotifen fumarate. | 2001 Mar-Apr |
|
Microemulsions for dermal drug delivery studied by dynamic light scattering: effect of interparticle interactions in oil-in-water microemulsions. | 2003 Apr |
|
Biocompatible lecithin organogels: structure and phase equilibria. | 2005 Jan 4 |
|
The hairless guinea-pig as a model for treatment of acute irritation in humans. | 2006 Aug |
|
The hairless guinea-pig as a model for treatment of cumulative irritation in humans. | 2006 Feb |
|
[Analysis of constituents of essential oil from the skin of water caltrop]. | 2006 Jan |
|
Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. | 2006 Jun |
|
Characterization of microemulsion structures in the pseudoternary phase diagram of isopropyl palmitate/water/Brij 97:1-butanol. | 2006 May 12 |
|
Characterisation of microstructures formed in isopropyl palmitate/water/Aerosol OT:1-butanol (2:1) system. | 2006 Nov |
|
Effects of isopropyl palmitate on the skin permeation of drugs. | 2006 Nov |
|
Microemulsions as transdermal drug delivery vehicles. | 2006 Nov 16 |
|
Investigation of fatty acid esters to replace isopropyl myristate in the sterility test for ophthalmic ointments. | 2006 Nov 16 |
|
Effect of penetration enhancers on skin permeation of trazodone hydrochloride from matrix type transdermal formulation through mouse and human cadaver epidermis. | 2006 Nov-Dec |
|
Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions. | 2007 |
|
Transdermal permeability of N-acetyl-D-glucosamine. | 2007 |
|
Lecithin organogels used as bioactive compounds carriers. A microdomain properties investigation. | 2007 Apr 10 |
|
Use of bone wax during laparoscopic renal ablative procedures: optimizing port utilization and reducing tract-site exposure. | 2007 Oct-Dec |
|
Aerosol OT microemulsions as carriers for transdermal delivery of hydrophobic and hydrophilic local anesthetics. | 2008 Jun |
|
Topical delivery of flurbiprofen from pluronic lecithin organogel. | 2009 Jan |
|
Microemulsions as a surrogate carrier for dermal drug delivery. | 2009 May |
|
Foreign body reaction to bone wax an unusual cause of persistent serous discharge from iliac crest graft donor site and the possible means to avoid such complication - a case report. | 2009 Nov 27 |
|
Pluronic lecithin organogel as a topical drug delivery system. | 2010 Jan |
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7284784
Isopropyl palmitate inhibited 44% of N-palmitoylethanolamine-selective acid amidase (NPAA) from rat lung homogenates at 100 uM
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:42 GMT 2023
by
admin
on
Fri Dec 15 15:00:42 GMT 2023
|
Record UNII |
8CRQ2TH63M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
208
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
142-91-6
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
C005060
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
DTXSID9027104
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
8CRQ2TH63M
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
ISOPROPYL PALMITATE
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
205-571-1
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
1350603
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL139055
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
2647
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
8CRQ2TH63M
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
100000077587
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
69169
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
84262
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
SUB14282MIG
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
1311179
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | RxNorm | ||
|
C76718
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY | |||
|
8907
Created by
admin on Fri Dec 15 15:00:42 GMT 2023 , Edited by admin on Fri Dec 15 15:00:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |